SCHEMBL6701015

SCHEMBL6701015

COC(=O)c1ccc2c(c1)nc(-c1ccc(O)cc1)n2-c1ccccc1

nearest known ligand 0.68

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SIRT2 Q8IXJ6 2/20 0.68
SIRT1 Q96EB6 2/20 0.68
ESR1 P03372 1/20 0.53
ESR2 Q92731 1/20 0.53
HSD17B10 Q99714 2/20 0.53
FGFR1 P11362 1/20 0.53
PTGER4 P35408 2/20 0.53
HPGD P15428 3/20 0.50
KDM4E B2RXH2 3/20 0.50
CYP1A2 P05177 1/20 0.50
CYP3A4 P08684 1/20 0.50
CYP2D6 P10635 1/20 0.50
MAPT P10636 1/20 0.50
CYP2C9 P11712 1/20 0.50
PKM P14618 1/20 0.50
ALOX15 P16050 1/20 0.50
CYP2C19 P33261 1/20 0.50
GRIA1 P42261 1/20 0.49
CACNG8 Q8WXS5 1/20 0.49
CACNG2 Q9Y698 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6439134 0.86 ESR2 (0.66) SIRT2SIRT1ESR1ESR2HSD17B10
SCHEMBL541343 0.83 HSD17B10 (0.76) SIRT2SIRT1HSD17B10FGFR1HPGD
SCHEMBL6789587 0.82 SIRT2 (0.47) SIRT2SIRT1ESR1ESR2HSD17B10
SCHEMBL5579900 0.81 ESR1 (0.68) SIRT2SIRT1ESR1ESR2HSD17B10
SCHEMBL12089843 0.80 FGFR1 (0.58) SIRT2SIRT1HSD17B10FGFR1HPGD
SCHEMBL26931778 0.78 SIRT2 (0.60) SIRT2SIRT1PTGER4HPGDKDM4E
SCHEMBL29829285 0.78 SIRT2 (0.60) SIRT2SIRT1PTGER4HPGDKDM4E
SCHEMBL5065691 0.77 RPS6KB1 (0.61) PTGER4KDM4EALOX15ALDH1A1ATM
SCHEMBL8023395 0.77 SIRT2 (0.61) SIRT2SIRT1HSD17B10FGFR1PTGER4
SCHEMBL422989 0.76 ALDH1A1 (0.50) SIRT2SIRT1ESR1ESR2HSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1429759-A4 COMPOUNDS USEFUL FOR TREATING HEPATITUS C VIRUS BRISTOL MYERS SQUIBB CO (US) 2004-12-15 EP disclosed
EP-1429759-A2 COMPOUNDS USEFUL FOR TREATING HEPATITUS C VIRUS Bristol-Myers Squibb Company (US) 2004-06-23 EP disclosed
WO-2003026587-A2 COMPOUNDS USEFUL FOR TREATING HEPATITUS C VIRUS BRISTOL-MYERS SQUIBB COMPANY (US) 2003-04-03 WO disclosed